Vertex Pharmaceuticals

VRTX

Market cap $105B

President Trump recently reminded investors that it doesn't take much to send a buoyant stock market reeling. When the market opened on Friday, Oct. 10, 2025, the Nasdaq Composite (^IXIC -0.76%) index traded above $23,100 for the first time.

Healthcare stocks have struggled since interest rates began climbing in 2022. Rising yields pulled capital away from speculative biotech and drug development, pushing valuations lower even as research pipelines advanced.

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $414.86, representing a -1.49% change from its previous close.

Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Warren Buffett famously said that he and his investing managers "attempt to be fearful when others are greedy, and to be greedy only when others are fearful." With the stock market near a record high, many investors are a lot greedier than they are fearful right now.

Earlier this year, all three major indexes -- the S&P 500, the Nasdaq, and the Dow Jones Industrial Average -- slid as President Donald Trump announced his plan to impose tariffs on imports. Investors worried this would result in higher costs for U.S. companies as they import their goods made abroad -- and this might sink earnings.

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2025 financial results on Monday, November 3, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1 (412) 317-0651 (International) and reference the “Vertex Pharmaceuticals Third Quarter 2025 Earnings Call.” The conference call will be webcast live and a link to the webcast ca.

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Equity markets are said to be forward looking. However, sometimes they fail to look far enough into the future by reacting too harshly to the challenges some companies face in the present.

In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $403.3, indicating a -1.36% shift from the previous trading day.